Recent Updates
Recently added Catalysts

tympanostomy tube

Phase 2

Otitis Media With Effusion | Unknown | ENT |Integra LifeSciences Holdings Corporation|Last Updated: Aug 6, 2024

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
UNCONTROLLEDBiomarker
Total Trials1
Total Enrollment53
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01202578Evaluation of the Tympanostomy Tube Delivery SystemPHASE2 COMPLETED 53Sep 1, 2010Dec 1, 2010Aug 6, 20244 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Safety of Tympanostomy Tube (TT) Delivery System
7 days

Occurrence of pre-defined Safety Events of acoustic trauma, deployment of the TT into the middle ear, damage to middle ear structures, unintended tympanic membrane perforation requiring treatment, abrasion to the external acoustic meatus requiring significant treatment, and major bleeding requiring significant treatment.

Device Success
0 days

Device Success is defined as the successful delivery of the tympanostomy tube across the tympanic membrane using the tympanostomy tube delivery system (TTDS).Device Success is evaluated on a per device basis.

Secondary Endpoints
Proportion of Subjects With Procedure Success
0 days
Tube Retention
7 days
Unlock Study Endpoints
Study Design & Arms
AllocationNA
MaskingNONE
ModelSINGLE_GROUP
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
tympanostomy tubeEXPERIMENTALperformance and safety of tympanostomy tube delivery system
Interventions
NameTypeDescription
tympanostomy tubeDEVICEtympanostomy tube delivery system
Unlock Study Design Details
Eligibility Criteria
Age Range6 Months — N/A
SexALL
Healthy VolunteersNo
Study Sites4

Inclusion Criteria: * Diagnosed with either chronic otitis media with effusion or acute otitis media and scheduled to undergo tympanostomy tube insertion Exclusion Criteria: * Reaction to anesthesia * Markedly atrophic, bimeric, severely retracted, atelectatic or perforated tympanic membrane * Ot...

Countries:United States
Unlock Eligibility Criteria